In addition to the correlation between GALNT14-rs9679162 and chemotherapy treatment outcomes in HCC, the predictive role of GALNT14-rs9679162 has also been demonstrated in several other types of GI cancers, including cholangiocarcinoma, colorectal cancer, gastric signet ring cell cancer, and esophageal squamous cell cancer. Here, GALNT14 is linked to cholangiocarcinoma.